Valcon Pharma SRL
Valcon Pharma reported total assets of 110,665 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Aug 2026).
The score of Valcon Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Valcon Pharma's annual accounts
| 2025 | |
|---|---|
| Net result | 76,262 € |
| Equity | 81,262 € |
| Cash | 68,312 € |
| EBITDA | 105,860 € |
| Total assets | 110,665 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
Valcon Pharma's financial analysis
- Solvency73.4%sector median: 56.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Valcon Pharma
Valcon Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1020.805.333
- VAT number
- BE1020805333
- Peppol
- Registered · 0208:1020805333 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Mar 2025
- Registered office
- 2811 Mechelen
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Public relations and communication activities (NACE 73300)
Valcon Pharma (SRL) has been based in Mechelen since 2025, active in: public relations and communication activities. For 2025, it reports a net profit of 76,262 € and equity of 81,262 €; its revenue is not published. Its solvency stands at 73.4%, above the median of its sector (56.8%).
Companies similar to Valcon Pharma
Companies in the same business, of comparable size and area, outside its group.
- TB Strategy & Management Public relations and communication activities Dendermonde · balance sheet 99,621 €
- Lunn Consulting Public relations and communication activities Lasne · balance sheet 784 €
- MAPL Public relations and communication activities Ixelles · balance sheet 110,934 €
- Capmeron Public relations and communication activities Sint-Genesius-Rode · balance sheet 133,223 €
- Archisap Public relations and communication activities Landen · balance sheet 116,304 €
- OrkaCon Public relations and communication activities Antwerp · balance sheet 97,215 €
- Lookahead Public relations and communication activities Diest · balance sheet 103,044 €
- Stefaan Osaer Consulting Public relations and communication activities Jabbeke · balance sheet 104,067 €
Frequently asked questions about Valcon Pharma
What is the revenue of Valcon Pharma?
Valcon Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Valcon Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1020805333 for Valcon Pharma, if the company is VAT-registered. Its company number (CBE) is 1020.805.333.
Where is the registered office of Valcon Pharma?
According to the CBE register, the registered office of Valcon Pharma is in 2811 Mechelen.
What is the equity of Valcon Pharma?
At the close of the 2025 financial year, the equity of Valcon Pharma amounts to 81,262 €, a solvency of 73.4% of total assets.
Who manages Valcon Pharma?
The register lists 1 active mandates at Valcon Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Valcon Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →